Dan Cleary

Dan Cleary is the Business Unit Head for GI & GU Cancers at AstraZeneca, leading initiatives in the Oncology sector. Previously, Dan served as Head of Sales for Oncology, where they played a pivotal role in brand strategy and market shaping within the Lung Cancer Portfolio. With a comprehensive background in Haematology, Oncology, Diabetes, Cardiovascular, Bone, and Metabolism, Dan has a strong track record of driving business growth and inspiring high-performing teams. Dan has also held leadership positions in renowned organizations, including the Chief Executive Officer of StemLife and various roles at Sanofi, Merck, and Novartis. Dan earned a Bachelor of Science in Physiology and Pharmacology from The University of Queensland.